Skip to main content
Livermore
Livermore
ZHEN

Ensign Peak Advisors, Inc

SEC CIK
0001454984
Latest filing
Aug 14, 2026

TMO holding history

Thermo Fisher Scientific Inc. in every 13F filed by Ensign Peak Advisors, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TMO overviewAll 13F holders of TMOFull Q2 2026 holdings

Shares (Q2 2026)
407,064
Value
$204.1M
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of TMO by Ensign Peak Advisors, Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026407,064$204.1M0.3%−109,506−21.2%ReducedHolders
Q1 2026516,570$253.9M0.5%−232,605−31.0%ReducedHolders
Q4 2025749,175$434.1M0.8%−48,419−6.1%ReducedHolders
Q3 2025797,594$386.8M0.6%+271,007+51.5%AddedHolders
Q2 2025526,587$213.5M0.4%−246,822−31.9%ReducedHolders
Q1 2025773,409$384.8M0.7%−287,534−27.1%ReducedHolders
Q4 20241,060,943$551.9M1.0%−22,086−2.0%ReducedHolders
Q3 20241,083,029$669.9M1.2%−90,466−7.7%ReducedHolders
Q2 20241,173,495$648.9M1.2%−46,164−3.8%ReducedHolders
Q1 20241,219,659$708.9M1.3%+132,781+12.2%AddedHolders
Q4 20231,086,878$576.9M1.1%+233,126+27.3%AddedHolders
Q3 2023853,752$432.1M0.9%+62,973+8.0%AddedHolders
Q2 2023790,779$412.6M0.8%+23,195+3.0%AddedHolders
Q1 2023767,584$442.4M1.0%+2,863+0.4%AddedHolders
Q4 2022764,721$421.1M0.9%−14,563−1.9%ReducedHolders
Q3 2022779,284$395.2M1.0%+19,273+2.5%AddedHolders
Q2 2022760,011$412.9M1.0%+6,694+0.9%AddedHolders
Q1 2022753,317$444.9M0.9%−51,943−6.5%ReducedHolders
Q4 2021805,260$537.3M1.0%−16,682−2.0%ReducedHolders
Q3 2021821,942$469.6M1.0%−34,857−4.1%ReducedHolders
Q2 2021856,799$432.2M0.9%−19,822−2.3%ReducedHolders
Q1 2021876,621$400.1M0.9%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.